|
IMUX Immunic Inc 1280776 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-32,588,000.00 |
| Balance Sheet |
|
Current Assets
|
$188,759,000.00 |
|
Assets
|
$189,742,000.00 |
|
Current Liabilities
|
$38,363,000.00 |
|
Liabilities
|
$38,509,000.00 |
|
Equity
|
$151,233,000.00 |
|
Shares Out
|
13621483.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-17,301,000.00 |
|
Investing Cash Flow
|
$-2,000.00 |
| Market Analysis |
Market Cap
|
$190,564,547.17 |
|
Price
|
$14.00 |
|
BVPS
|
11.10 |
|
PB
|
1.26 |
|
EPS
|
-1.08 |
|
FCF
|
$-17,303,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:32 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.62 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-13 |
-1.08 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.20 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMUX documents filed with the SEC.
IMUX Filings
Clear
